Snyder's new book, "Genomics and Personalized Medicine," serves as a primer for patients and doctors, touching on topics from tailored cancer therapy to wearable devices.
The firm performed a long-term, prospective study and noted that the test improved outcomes for patients and helped doctors monitor patients with benign disease.
Low-coverage, whole-genome sequencing had a diagnostic yield of up to 53 percent in prenatal and postnatal samples referred for chromosomal analyses.
Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.
In a panel at this week's Personalized Medicine World Conference, executives and researchers discussed moving genomics into the promotion of lifetime health and prevention of disease.
In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.
It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.
A proposed bill would require NSF to only fund research that's in "the national interest."
Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.
This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.
This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.